376 related articles for article (PubMed ID: 7902528)
1. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
[TBL] [Abstract][Full Text] [Related]
2. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4.
Cabrera C; Witvrouw M; Gutiérrez A; Clotet B; Kuipers ME; Swart PJ; Meijer DK; Desmyter J; De Clercq E; Esté JA
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1535-43. PubMed ID: 10580404
[TBL] [Abstract][Full Text] [Related]
3. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
Jansen RW; Molema G; Pauwels R; Schols D; De Clercq E; Meijer DK
Mol Pharmacol; 1991 Jun; 39(6):818-23. PubMed ID: 2051994
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of replication of primary HIV type 1 isolates in peripheral blood lymphocytes by negatively charged human serum albumins.
Groenink M; Swart PJ; Broersen S; Kuipers M; Meijer DK; Schuitemaker H
AIDS Res Hum Retroviruses; 1997 Jan; 13(2):179-85. PubMed ID: 9007203
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA.
Swart PJ; Beljaars E; Smit C; Pasma A; Schuitemaker H; Meijer DK
J Drug Target; 1996; 4(2):109-16. PubMed ID: 8894971
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV-1 activity of combinations and covalent conjugates of negatively charged human serum albumins (NCAs) and AZT.
Kuipers ME; Swart PJ; Witvrouw M; Esté JA; Reymen D; De Clercq E; Meijer DK
J Drug Target; 1999; 6(5):323-35. PubMed ID: 10342381
[TBL] [Abstract][Full Text] [Related]
8. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission.
Leydet A; Moullet C; Roque JP; Witvrouw M; Pannecouque C; Andrei G; Snoeck R; Neyts J; Schols D; De Clercq E
J Med Chem; 1998 Dec; 41(25):4927-32. PubMed ID: 9836609
[TBL] [Abstract][Full Text] [Related]
9. Charge modification of plasma and milk proteins results in antiviral active compounds.
Swart PJ; Harmsen MC; Kuipers ME; Van Dijk AA; Van Der Strate BW; Van Berkel PH; Nuijens JH; Smit C; Witvrouw M; De Clercq E; de Béthune MP; Pauwels R; Meijer DK
J Pept Sci; 1999 Dec; 5(12):563-76. PubMed ID: 10628656
[TBL] [Abstract][Full Text] [Related]
10. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
11. The influence of charge clustering on the anti-HIV-1 activity and in vivo distribution of negatively charged albumins.
Beljaars L; Floris R; Berkhout B; Smit C; Meijer DK; Molema G
Biochem Pharmacol; 2002 May; 63(9):1663-73. PubMed ID: 12007569
[TBL] [Abstract][Full Text] [Related]
12. Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
Tamamura H; Otaka A; Murakami T; Ishihara T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
Biochem Biophys Res Commun; 1996 Feb; 219(2):555-9. PubMed ID: 8605026
[TBL] [Abstract][Full Text] [Related]
13. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of influenza virus fusion by polyanionic proteins.
Schoen P; Corver J; Meijer DK; Wilschut J; Swart PJ
Biochem Pharmacol; 1997 Apr; 53(7):995-1003. PubMed ID: 9174113
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: drug carriers with an intrinsic anti-HIV activity.
Kamps JA; Swart PJ; Morselt HW; Pauwels R; De Béthune MP; De Clercq E; Meijer DK; Scherphof GL
Biochim Biophys Acta; 1996 Jan; 1278(2):183-90. PubMed ID: 8593275
[TBL] [Abstract][Full Text] [Related]
16. Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.
Jagodzinski PP; Wustner J; Kmieciak D; Wasik TJ; Fertala A; Sieron AL; Takahashi M; Tsuji T; Mimura T; Fung MS; Gorny MK; Kloczewiak M; Kaneko Y; Kozbor D
Virology; 1996 Dec; 226(2):217-27. PubMed ID: 8955041
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of anti-HIV activity of succinylated human serum albumin.
Kuipers ME; vd Berg M; Swart PJ; Laman JD; Meijer DK; Koppelman MH; Huisman H
Biochem Pharmacol; 1999 Apr; 57(8):889-98. PubMed ID: 10086322
[TBL] [Abstract][Full Text] [Related]
19. The in vitro anti-HIV efficacy of negatively charged human serum albumin is antagonized by heparin.
Swart PJ; Sun CS; Kuipers ME; Asuncion C; Josephs S; Smit C; Meijer DK
AIDS Res Hum Retroviruses; 1997 May; 13(8):677-83. PubMed ID: 9168236
[TBL] [Abstract][Full Text] [Related]
20. Polyanion inhibitors of human immunodeficiency virus and other viruses. 5. Telomerized anionic surfactants derived from amino acids.
Leydet A; Barragan V; Boyer B; Montéro JL; Roque JP; Witvrouw M; Este J; Snoeck R; Andrei G; De Clercq E
J Med Chem; 1997 Jan; 40(3):342-9. PubMed ID: 9022800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
